» Articles » PMID: 25035341

Impaired Fibrous Repair: a Possible Contributor to Atherosclerotic Plaque Vulnerability in Patients with Type II Diabetes

Overview
Date 2014 Jul 19
PMID 25035341
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetes mellitus (DM) type II is increasing rapidly worldwide. Patients with DM II have a greater atherosclerotic burden and higher risk of developing cardiovascular complications. Inflammation has been proposed as the main cause for the high risk of atherosclerotic disease in DM II. In this study, we compared markers of inflammation and fibrous repair in plaques from subjects with and without DM II.

Approach And Results: Carotid endarterectomy specimens were obtained from 63 patients with and 131 without DM. Plaque structure, connective tissue proteins, inflammatory cells, and markers were analyzed by immunohistochemistry, ELISA, Mesoscale, and Luminex technology. Carotid plaques from diabetics had lower levels of extracellular matrix proteins, elastin, and collagen, which are critical for plaque stability. Plaques from diabetics had reduced levels of platelet-derived growth factor and matrix metalloproteinase-2, both important for tissue repair. No differences were observed in inflammatory markers in plaques from diabetic and nondiabetic patients.

Conclusion: This study suggests that atherosclerotic plaques in subjects with DM II are more prone to rupture because of impaired repair responses rather than to increased vascular inflammation. Although this study did not have a mechanistic design, our findings suggest that targeting impaired repair responses in carotid plaques may help to increase our understanding of atherosclerotic plaque development and vulnerability in patients with DM II.

Citing Articles

Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Singh P, Sun J, Cavalera M, Al-Sharify D, Matthes F, Barghouth M Nat Commun. 2024; 15(1):10464.

PMID: 39653743 PMC: 11628557. DOI: 10.1038/s41467-024-50753-8.


Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis increasing the risk of cerebrovascular complications.

Dib L, Koneva L, Edsfeldt A, Zurke Y, Sun J, Nitulescu M Nat Cardiovasc Res. 2024; 2(7):656-672.

PMID: 38362263 PMC: 7615632. DOI: 10.1038/s44161-023-00295-x.


Risk factors and the CCTA application in patients with vulnerable coronary plaque in type 2 diabetes: a retrospective study.

He W, Fang T, Fu X, Lao M, Xiao X BMC Cardiovasc Disord. 2024; 24(1):89.

PMID: 38311736 PMC: 10840286. DOI: 10.1186/s12872-024-03717-1.


Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice.

Zhong T, Gao N, Guan Y, Liu Z, Guan J ACS Nano. 2023; 17(24):25157-25174.

PMID: 38063490 PMC: 10790628. DOI: 10.1021/acsnano.3c08088.


Plasma type I collagen α1 chain in relation to coronary artery disease: findings from a prospective population-based cohort and an acute myocardial infarction prospective cohort in Sweden.

Hammareus F, Nilsson L, Ong K, Kristenson M, Festin K, Lundberg A BMJ Open. 2023; 13(9):e073561.

PMID: 37714678 PMC: 10510861. DOI: 10.1136/bmjopen-2023-073561.